GPGI, Inc. Investors Have Opportunity to Lead Securities Fraud Lawsuit
Rosen Law Firm is reminding investors who purchased GPGI, Inc. (f/k/a CompoSecure) stock during a specific period of an opportunity to lead a securities fraud lawsuit.

Rosen Law Firm, an international investor rights law firm, is reminding purchasers of Class A common stock of GPGI, Inc. f/k/a CompoSecure, Inc. (NYSE: GPGI, CMPO) between November 3, 2025, and May 6, 2026, inclusive, of an important opportunity. This period is referred to as the "Class Period."
The firm is seeking investors to serve as lead plaintiff in a securities fraud lawsuit against the company and its officers. The lawsuit alleges that the defendants engaged in securities fraud and violated federal securities laws. Specific details regarding the lawsuit can be found on Rosen Law Firm's website.
Investors interested in pursuing this matter are urged to contact Rosen Law Firm promptly, as the deadline to seek lead plaintiff status is approaching. GPGI, Inc., formerly known as CompoSecure, Inc., is traded on the New York Stock Exchange under the tickers GPGI and CMPO.
The lawsuit aims to recover losses for investors who purchased securities during the specified Class Period and allegedly suffered damages due to misrepresentations or omissions made by the company. Rosen Law Firm has extensive experience in prosecuting class action securities and other shareholder derivative lawsuits.